141 related articles for article (PubMed ID: 15771416)
1. A bivalent ligand (KDAN-18) containing delta-antagonist and kappa-agonist pharmacophores bridges delta2 and kappa1 opioid receptor phenotypes.
Daniels DJ; Kulkarni A; Xie Z; Bhushan RG; Portoghese PS
J Med Chem; 2005 Mar; 48(6):1713-6. PubMed ID: 15771416
[TBL] [Abstract][Full Text] [Related]
2. A bivalent ligand (KDN-21) reveals spinal delta and kappa opioid receptors are organized as heterodimers that give rise to delta(1) and kappa(2) phenotypes. Selective targeting of delta-kappa heterodimers.
Bhushan RG; Sharma SK; Xie Z; Daniels DJ; Portoghese PS
J Med Chem; 2004 Jun; 47(12):2969-72. PubMed ID: 15163177
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
[TBL] [Abstract][Full Text] [Related]
4. Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.
Ansonoff MA; Portoghese PS; Pintar JE
Psychopharmacology (Berl); 2010 Jun; 210(2):161-8. PubMed ID: 20333506
[TBL] [Abstract][Full Text] [Related]
5. The role of the side chain in determining relative delta- and kappa-affinity in C5'-substituted analogues of naltrindole.
Black SL; Jales AR; Brandt W; Lewis JW; Husbands SM
J Med Chem; 2003 Jan; 46(2):314-7. PubMed ID: 12519069
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
7. Interaction of bivalent ligand KDN21 with heterodimeric delta-kappa opioid receptors in human embryonic kidney 293 cells.
Xie Z; Bhushan RG; Daniels DJ; Portoghese PS
Mol Pharmacol; 2005 Oct; 68(4):1079-86. PubMed ID: 16006595
[TBL] [Abstract][Full Text] [Related]
8. Major effect of pyrrolic N-benzylation in norbinaltorphimine, the selective kappa-opioid receptor antagonist.
Chauvignac C; Miller CN; Srivastava SK; Lewis JW; Husbands SM; Traynor JR
J Med Chem; 2005 Mar; 48(5):1676-9. PubMed ID: 15743210
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and preliminary in vitro investigation of bivalent ligands containing homo- and heterodimeric pharmacophores at mu, delta, and kappa opioid receptors.
Peng X; Knapp BI; Bidlack JM; Neumeyer JL
J Med Chem; 2006 Jan; 49(1):256-62. PubMed ID: 16392810
[TBL] [Abstract][Full Text] [Related]
10. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
[TBL] [Abstract][Full Text] [Related]
11. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
12. Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice.
Lunzer MM; Portoghese PS
J Pharmacol Exp Ther; 2007 Jul; 322(1):166-71. PubMed ID: 17400888
[TBL] [Abstract][Full Text] [Related]
13. A bivalent ligand (KMN-21) antagonist for mu/kappa heterodimeric opioid receptors.
Zhang S; Yekkirala A; Tang Y; Portoghese PS
Bioorg Med Chem Lett; 2009 Dec; 19(24):6978-80. PubMed ID: 19892550
[TBL] [Abstract][Full Text] [Related]
14. BU48: a novel buprenorphine analog that exhibits delta-opioid-mediated convulsions but not delta-opioid-mediated antinociception in mice.
Broom DC; Guo L; Coop A; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):1195-200. PubMed ID: 10945877
[TBL] [Abstract][Full Text] [Related]
15. Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.
Daniels DJ; Lenard NR; Etienne CL; Law PY; Roerig SC; Portoghese PS
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):19208-13. PubMed ID: 16365317
[TBL] [Abstract][Full Text] [Related]
16. Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.
Le Naour M; Lunzer MM; Powers MD; Portoghese PS
J Med Chem; 2012 Jan; 55(2):670-7. PubMed ID: 22136373
[TBL] [Abstract][Full Text] [Related]
17. Importance of phenolic address groups in opioid kappa receptor selective antagonists.
Thomas JB; Fix SE; Rothman RB; Mascarella SW; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
J Med Chem; 2004 Feb; 47(4):1070-3. PubMed ID: 14761209
[TBL] [Abstract][Full Text] [Related]
18. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
19. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.
Fang X; Larson DL; Portoghese PS
J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669
[TBL] [Abstract][Full Text] [Related]
20. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
Makó E; Rónai AZ
Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
